NDC 31260-402 - SUCRALFATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 31260-402
- Package NDCs from labels
- 31260-402-01, 31260-402-02
- Manufacturer
- Gulbrandsen Technologies India Private Limited
- Effective date
- 2026-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SUCRALFATE - Gulbrandsen Technologies India Private Limited | Gulbrandsen Technologies India Private Limited | 2026-04-03 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 31260-402-01 | SUCRALFATE | 25 kg in 1 DRUM | POWDER | 25 | 3 | |
| 31260-402-02 | SUCRALFATE | 0.5 kg in 1 CONTAINER | POWDER | 0.5 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sucralfate | SUCRALFATE | Advanced Rx of Tennessee, LLC | b39f22c8-f224-451a-e053-2995a90aaad7 | 2024-12-31 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Advanced Rx Pharmacy of Tennessee, LLC | d3c41720-7e1a-08c1-e053-2a95a90aba03 | 2024-12-31 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Advanced Rx Pharmacy of Tennessee, LLC | f15fbb45-4406-0d32-e053-2995a90a40c5 | 2024-12-31 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Cosette Pharmaceuticals, Inc. | 3054ce94-78a2-4da4-8b14-95311b412ab2 | 2024-11-25 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | Amneal Pharmaceuticals LLC | 4350b771-76a9-4e00-93f0-a18c71288f83 | 2024-10-30 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | a068e818-8da3-4f0d-88e0-acc88e76f3aa | 2024-08-22 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | NuCare Pharmaceuticals,Inc. | a40e43d4-9240-34ad-e053-2995a90a98e1 | 2024-07-15 | Adverse reactions | XX73205DH5 |
| Carafate | SUCRALFATE | Allergan, Inc. | c87c6b50-6977-4fa7-ae98-40c0753f7aee | 2024-05-21 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Proficient Rx LP | 51459cdb-a04a-49c2-8ee4-8f234f522476 | 2024-05-01 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Advanced Rx Pharmacy of Tennessee, LLC | 138f0929-caad-56c6-e063-6294a90a55ef | 2024-03-13 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Amneal Pharmaceuticals NY LLC | b2e07ac7-4a8a-4b68-bb65-167d1aa86883 | 2024-03-01 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 28d7d257-8545-4b9f-8412-8ba144502400 | 2024-02-23 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Pacific Pharma, Inc. | 7407c58e-766f-4e93-a1bb-c77892ae0174 | 2024-02-10 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 7b05323d-4695-41d7-8236-1e7b4e8f2a1e | 2024-01-11 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 25ae2ebc-a7e0-4fc9-a8d1-07f7dd7138e5 | 2024-01-11 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Proficient Rx LP | a42c5f3d-85f1-485b-91e6-58c25b3ddc71 | 2024-01-01 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Amneal Pharmaceuticals NY LLC | a4f722e7-2885-4f27-8358-9c662439600a | 2023-12-30 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | American Health Packaging | e4761fb2-6a1a-44de-9d27-f6addabc24c8 | 2023-08-10 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | A-S Medication Solutions | 793d033d-d341-4910-8dda-d43d8fd03a4d | 2023-06-29 | Adverse reactions | XX73205DH5 |
| Carafate | SUCRALFATE | Allergan, Inc. | 0fb67b1c-b4c0-46f2-8a81-df1510e006aa | 2023-06-08 | Warnings, Adverse reactions | XX73205DH5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.